Share URL
Embed chart view
StockViz
Exact Sciences Corporation
NasdaqCM:EXAS
Sector
Location
Market Cap
USD 8.63 B
Share Price
USD 45.60
Avg Daily Volume
3,195,001
Change (1 day)
1.36%
Change (1 year)
-22.01%
Change (YTD)
-18.85%
Exact Sciences Corporation Share Price Year-To-Date (YTD) return on August 15, 2025: -18.85%
Exact Sciences Corporation Share Price Year-To-Date (YTD) return is -18.85% on August 15, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
Exact Sciences Corporation 52-week low Share Price is USD 71.93 on August 15, 2025, which is 57.74% above the current Share Price.
-
Exact Sciences Corporation 52-week low Share Price is USD 40.31 on August 15, 2025, which is -11.60% below the current Share Price.
-
Exact Sciences Corporation average Share Price for the last 52 weeks is USD 55.00.
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Boston Scientific Corporation
USD 103.17
BSX
-0.98
-0.94%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Sartorius Stedim Biotech S.A.
USD 207.65
DIM.PA
+1.46
0.71%
bioMérieux S.A.
USD 147.37
BIM.PA
+0.01
0.01%
United Therapeutics Corporation
USD 313.13
UTHR
+1.07
0.34%
Medpace Holdings, Inc.
USD 457.85
MEDP
-0.81
-0.18%
Revvity, Inc.
USD 90.78
RVTY
+1.33
1.49%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Sysmex Corporation
USD 13.59
6869.T
+0.10
0.73%
Bio-Techne Corporation
USD 53.60
TECH
-0.14
-0.26%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.99
002294.SZ
+0.29
4.39%
Guardant Health, Inc.
USD 58.88
GH
-1.48
-2.45%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Boston Scientific Corporation
USD 103.17
BSX
-0.98
-0.94%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Sartorius Stedim Biotech S.A.
USD 207.65
DIM.PA
+1.46
0.71%
bioMérieux S.A.
USD 147.37
BIM.PA
+0.01
0.01%
United Therapeutics Corporation
USD 313.13
UTHR
+1.07
0.34%
Medpace Holdings, Inc.
USD 457.85
MEDP
-0.81
-0.18%
Revvity, Inc.
USD 90.78
RVTY
+1.33
1.49%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Sysmex Corporation
USD 13.59
6869.T
+0.10
0.73%
Bio-Techne Corporation
USD 53.60
TECH
-0.14
-0.26%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.99
002294.SZ
+0.29
4.39%
Guardant Health, Inc.
USD 58.88
GH
-1.48
-2.45%